Influence of low-dose daily cisplatin on the distant metastasis-free survival of patients with locally advanced nonmetastatic head and neck cancer treated with radiation therapy

Radiotherapy and Oncology

Volumn 87, Issue 2, 2008, Pages 201-203

  Jeremić, Branislav ^a   Miličić, Biljana ^a  

^a University Hospital   (Serbia)

Author keywords

Cisplatin local control; Distant metastasis; Head and neck cancer; Hyperfractionation; Radiation therapy

Indexed keywords

CISPLATIN;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; HEAD AND NECK CANCER; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; NEOPLASM METASTASIS; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 43049154371     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.12.023     Document Type: Article

References (13)

1. Budach V., Stuschke M., Budach W., et al. Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German Cancer Society 95-06 Prospective Randomized Trial. J Clin Oncol 23 (2005) 1125-1135
2. Fountzilas G., Skarlos D., Kosmidis P., et al. Radiation therapy and concurrent cisplatin administration in locally advanced head and neck cancer. A Hellenic co-operative oncology group study. Acta Oncol 33 (1994) 825-830
3. Jeremic B., Shibamoto Y., Stanisavljevic B., et al. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomised trial. Radiother Oncol 43 (1997) 29-37
4. Jeremic B., Shibamoto Y., Milicic B., et al. Hyperfractionated radiation therapy with or without concurrent low-dose cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol 18 (2000) 1458-1464
5. Jeremic B., Milicic B., Dagovic A., et al. Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck. J Clin Oncol 22 (2004) 3540-3548
6. Marcial V.A., Pajak T.F., Mohiuddin M., et al. Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck: long term results of the Radiation Therapy Oncology Study 81-17. Cancer 66 (1990) 1866-1868
7. Pignon J.P., Bourhis J., Domenge C., and Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 18 (2000) 949-955
8. Pinnaro P., Cercato M.C., Giannerelli D., et al. A randomized phase II study comparing sequential versus simultaneous chemo-radiotherapy in patients with unresectable locally advanced squamous cell cancer of the head and neck. Ann Oncol 5 (1994) 513-520
9. Steel G.G., and Peckham M.J. Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys 5 (1979) 85-91
10. Suit H.D. Potential for improving survival rates for the cancer patient by increasing the efficacy of treatment of the primary lesion. Cancer 50 (1982) 1227-1234
11. Suit H.D., and Westgate S.J. Impact of improved local control on survival. Int J Radiat Oncol Biol Phys 12 (1986) 453-458
12. Suit H.D. The scope of the problem of primary tumor control. Cancer 61 (1988) 2141-2147
13. Suit H.D. Local control and patient survival. Int J Radiat Oncol Biol Phys 23 (1992) 653-660